Isomorphic Labs raised $5 billion to expand its AI drug design platform and move its first drug candidates toward human ...
Nov 19 (Reuters) - Celldex Therapeutics said on Thursday it would stop developing its experimental drug for eczema after the ...
Alterome presented preliminary Phase 1 results of its drug “selectively” targeting a range of KRAS mutations — drivers of ...
A review outlines key strategies to overcome clinical trial and regulatory hurdles in rare disease drug development.
By Michael Erman, Bhanvi Satija and Patrick Wingrove NEW YORK/LONDON, Nov 20 (Reuters) - Artificial intelligence has sped up ...
Novartis CEO Vasant Narasimhan says AI could cut drug development from 12 years to eight and lift success rates. Here's how ...
A comprehensive analysis of over 3,000 global clinical trials highlights the rapid development and regional concentration of ...
Novartis (NYSE:NVS) is applying artificial intelligence across drug research and clinical development, with executives ...
Most AI drug development firms are focused on discovery. AI biotech Formation Bio is betting the real bottleneck is clinical trials. With a new $600 million fund to buy or license potential drugs that ...
The U.S. FDA announced on Tuesday that Amgen (AMGN) and AstraZeneca (AZN) have initiated real-time clinical trials as the agency seeks to launch a pilot program designed to accelerate drug development ...
The US Food and Drug Administration (FDA) has finalized a guidance for industry on development of drugs and therapeutic biologics for treating eosinophilic esophagitis (EoE), a chronic, allergic ...
(This Nov 17 story has been repeated with no changes to text.) Nov 17 (Reuters) - Merck said on Tuesday it would stop ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results